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abstract: Artiﬁcial oocyte activation to overcome failed fertilization after intracytoplasmic sperm injection (ICSI) in human oocytes typically
employs Ca2+ ionophores to produce a single cytosolic Ca2+ increase. In contrast, recombinant phospholipase Czeta (PLCz) causes Ca2+ oscil-
lations indistinguishable from thoseoccurring during fertilization, but remains untested for its efﬁcacy in a scenario of ICSI fertilization failure.Here,
we compare PLCzwith other activation stimuli in a mouse model of failed oocyte activation after ICSI, in which heat-treated sperm are injected
intomouse oocytes.We show that increasing periods of 568Cexposure of sperm produces a progressive loss of Ca2+ oscillations after ICSI. The
decrease in Ca2+ oscillations produces a reduction in oocyte activation and embryo development to the blastocyst stage. We treated such
oocytes that failed to activate after ICSI either with Ca2+ ionophore, or with Sr2+ media which causes Ca2+ oscillations, or we injected them
with recombinant human PLCz. All these treatments rescued oocyte activation, although Sr2+ and PLCz gave the highest rates of development
to blastocyst.When recombinant PLCzwas given to oocytes previously injected with control sperm, they developed normally to the blastocyst
stage at rates similar to that after control ICSI. The data suggest that recombinant human PLCz protein is an efﬁcient means of rescuing oocyte
activation after ICSI failure and that it can be effectively used even if the sperm already contains endogenous Ca2+ releasing activity.
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Introduction
For couples attending in vitro fertilization (IVF) clinics, intracytoplasmic
sperm injection (ICSI) is a widely used treatment option (Palermo
et al., 1992; Johnson et al., 2013) that is remarkably successful, compared
with conventional IVF treatments, for treating many cases of male factor
infertility (Palermo et al., 1992; Johnson et al., 2013). However, cases of
ICSI where all of the available oocytes from a given collection fail to fer-
tilize (Yanagida, 2004) occur in 1–5% of all ICSI treatment cycles (Liu
et al., 1995). In such incidences of ICSI failure, the main cause has been
shown to be the lack of oocyte activation (Javed et al., 2010; Vanden
Meerschaut et al., 2013a; Neri et al., 2014). The options for couples
facing total fertilization failure are limited (Yuzpe et al., 2000; Heindryckx
et al., 2005). Total fertilization failure cases are relatively rare, partly
because typically 10 oocytes are available for sperm injection
(Sunkara et al., 2011). This multiplicity of oocytesmasks the fact that fer-
tilization after ICSI is less effective when rated per oocyte injected. For
example, using sperm and oocytes with apparently normal parameters
in cases where tubal blockage was the only evident cause of infertility,
only 67% of oocytes were activated after sperm injection (Bukulmez
et al., 2000), implying that one in three sperm is ineffective in activating
the oocyte. This recurrent failure per oocyte becomes a particular
concern when oocytes are limited, in mild ovarian stimulation or
natural ovulation cycles (Pelinck et al., 2002; Loutradis et al., 2007).
The activation ofmammalian oocytes at fertilization involves an exten-
sive series of Ca2+ transients, known as Ca2+ oscillations. Each Ca2+
spike lasts about 1 min and the Ca2+ transients occur at intervals of
5–30 min (Miyazaki and Ito, 2006; Swann and Lai, 2013). Such Ca2+
oscillations have been observed in human and mouse oocytes after in
vitro fertilization and ICSI (Sato et al., 1999). Such Ca2+ oscillations are
both necessary and sufﬁcient for oocyte activation (Kurokawa et al.,
2004) and may inﬂuence subsequent embryo development (Ducibella
et al., 2002; Yu et al., 2008). Accumulating scientiﬁc and clinical evidence
favours the idea that Ca2+ oscillations are triggered after sperm oocyte
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membrane fusion, which allows the entry of a sperm-speciﬁc PLC
isoform, termed PLCz, into the oocyte cytoplasm (Saunders et al.,
2002; Nomikos et al., 2005). Injection of PLCz cRNA or recombinant
protein stimulates parthenogenetic activation of mouse and human
oocytes, and subsequent development of mouse embryos up to the
blastocyst stage at rates similar to those seen after fertilization (Miyazaki,
1995).
Mouse oocytes have been frequently used as a model system for
studying human IVF and ICSI. The mouse oocyte has also been used
to directly test the ability of human sperm to cause oocyte activation
or Ca2+ oscillations after cross-species ICSI (Araki et al., 2004; Vanden
Meerschaut et al., 2013a). Injection of human sperm into mouse
oocytes can trigger oocyte activation, but sperm from failed clinical ICSI
cycles generally show a reduced ability to activate mouse oocytes after
injection (Araki et al., 2004; Vanden Meerschaut et al., 2013a). Further-
more, injecting human sperm into mouse oocytes also causes a series of
Ca2+ oscillations. The frequency of these human sperm-induced Ca2+
oscillations is often higher than observed at fertilization in mouse
oocytes (Yoon et al., 2012; Nikiforaki et al., 2014). This is probably
because human PLCz has a greater intrinsic potency than mouse PLCz
and is able to cause the same pattern of Ca2+ oscillations at 10
times lower concentrations than mouse PLCz (Yu et al., 2008). It has
been reported that sperm from men with repeated fertilization failure,
or with mutations in PLCz protein, show a markedly reduced ability to
cause Ca2+ oscillations after ICSI into mouse oocytes (Yoon et al.,
2008; Heytens et al., 2009; Kashir et al., 2011, 2012). However, it was
noteworthy that even for men who have had successful ICSI cycles,
only 55% of normal sperm cause high-frequency Ca2+ oscillations in
mouse oocytes (Vanden Meerschaut et al., 2013a; Nikiforaki et al.,
2014). These data suggest that in cases of human ICSI failure, there
might be either a deﬁciency, or relative lack of Ca2+ oscillations.
In cases of failed or poor rates of fertilization after ICSI, the only avail-
able treatment option is the use of artiﬁcial oocyte activation agents.
This usually consists of treating oocytes with Ca2+ ionophores, such as
A23187 or ionomycin, a procedure that has been successfully used to
overcome fertilization failure in many cases (Kyono et al., 2012).
Despite its apparent utility there are few controlled studies on the efﬁ-
cacy of Ca2+ ionophores as a means of rescuing failed oocyte activation
anddevelopment.Ca2+ ionophore application, as currently used inmost
clinics, only causes a single large Ca2+ increase that does not mimic the
series of Ca2+ oscillations seen at fertilization (Rinaudo et al., 1997).
Stimuli that elicitmultiple Ca2+ transients are known to be amoreeffect-
ive means of activating mammalian oocytes (Ozil and Swann, 1995;
Ducibella et al., 2002). Sr2+media can be used to cause such repetitive
Ca2+ oscillations in mouse oocytes, but Sr2+ has not been shown to
trigger Ca2+ release in human oocytes (Rogers et al., 2004). PLCz
remains the only physiological agent that has been repeatedly shown
to produce a prolonged series of Ca2+ oscillations in all mammalian
oocytes studied, including human oocytes (Ito et al., 2011; Nomikos
et al., 2013a, b; Kashir et al., 2014).
In this study, we have investigated whether recombinant human PLCz
protein can be used to rescue cases of failed fertilization or to improve
poor development rates after ICSI. We use a mouse model of failed
oocyte activation after ICSI by applying mild heat treatment of mouse
sperm.We ﬁnd that heat-treated sperm display a reduced ability to gen-
erate Ca2+ oscillations in mouse oocytes, consistent with consequent
observations of reduced preimplantation development. We also show
that fertilization failure and poor embryo development after ICSI with
heat-treated sperm can be rescued by subsequent microinjection of re-
combinant human PLCz protein, which along with Sr2+ media, is more
effective than Ca2+ ionophore. Moreover, we demonstrate that micro-
injection of PLCz after standard ICSI with normal, untreated sperm does
not impair embryo development. These data provide the basis for future
studies to examine the potential use of recombinant human PLCz as a
biological therapeutic to rescue human oocytes from failed fertilization
after ICSI.
Materials andMethods
All chemicals were obtained from Sigma Aldrich UK unless stated otherwise
and were of embryo grade where available. M2 media was used for handling
oocytes outside the incubator. KSOM was obtained from Merk-Millipore
(Watford, UK), or made as previously described (Summers et al., 1995).
The microinjection buffer was 100 mM KCl in 20 mM Hepes, pH 7.2
(Swann, 1990).
Gametes and embryos
Mouse oocytes were obtained from superovulated female MF1 mice as
described previously (Yu et al., 2008). Cumulus-oocyte masses from ovi-
ducts were incubated in hyaluronidase in M2 media, and then isolated
oocytes were washed in M2 media alone. Mouse embryos were cultured
in KSOM media (Summers et al., 1995) under mineral oil in an incubator at
378Cgassedwith 5%CO2.Mouse spermwere collected from the cauda epi-
didymis of euthanized male mice (C57xCBA F1 hybrid), released into T6
media (Jones et al., 1995) and in some cases, sperm were frozen in the
same media (without cryopreservation) in a 2808C freezer. For heat treat-
ment, sperm were incubated for the speciﬁed times in a water bath at 568C
then sonicated for 10 s before being added to drops containing the
oocytes. For Sr2+ activation after ICSI as described by Yoshida and Perry
(2007) using heat inactivated sperm for 30 min, oocytes were allowed to
recover for 30 min in M2. Oocytes were then incubated afterwards in
calcium-free HKSOM supplemented with 5 mM Sr2+ for 2 h after which
they are washed in M2 then cultured in KSOM under 5% CO2 in air at 378C.
Ethical approval
All procedures using animals were approved by Cardiff University Animals
Ethics Committee and carried out under a UKHomeOfﬁce Project Licence.
Microinjection
Mouse oocytes were microinjected with sperm using custom-made ICSI
pipettes (Yoshida and Perry, 2007). The micropipettes containing the
sperm were advanced through the oocyte plasma membrane using a piezo-
pulse delivered by a Prime Tech piezo manipulation system (Intracel,
Royston, UK). Recombinant PLCz was injected using a ﬁne tip micropipette
that was inserted into the oocyte using pressure pulses (Picopump, World
Precision Instruments, USA), as described previously (Saunders et al., 2002).
Ca21measurements
Cytosolic free Ca2+ concentrations were measured in individual mouse
oocytes by monitoring the ﬂuorescence of PE3 or Rhod dextran (Takahashi
et al., 1999). The PE3 dyewas loaded into oocytes by incubating for 30 min in
10 mMof PE3-AM (also known as fura2LeakRes-AM) dissolved inM2media.
PE3 is a similar dye to fura2 except that it does not undergo compartmental-
ization or extrusion from the cytosol and hence can be used for longer-term
recordings of Ca2+ (Takahashi et al., 1999). Oocytes were then washed free
of theAMdyeand allowed to equilibrate for another30 min beforemaking
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ﬂuorescencemeasurements. Rhod dextranwas injected into oocytes before
the start of experiments. The measurements of ﬂuorescence were made
by placing oocytes in drops of HKSOM media on a heated stage of a Nikon
TiU epiﬂuorescence microscope. For PE3 based recordings, oocytes were
exposed to ﬂuorescence excitation at 380 nm and emission measured at
510–550 nm (Takahashi et al., 1999). The ﬂuorescence ratio of the signals
at350and380 nmwas thenplottedagainst timeasameasureof relativecyto-
solic Ca2+ concentrations. In a similar manner for Rhod dextran, the ﬂuores-
cence was plotted against time with excitation at 550 nm and emission
collected at 580–620 nm (Swann and Lai, 2013).
Recombinant protein expression and
puriﬁcation
Human PLCz was expressed as a NusA-6xHis-tagged fusion protein and
puriﬁed by afﬁnity chromatography on Ni-NTA resin using standard proce-
dures (Qiagen) and elution with 275 mM imidazole, as described previously
(Nomikos et al., 2013b). NusA tagged human PLCzwas tested for its ability
to causeCa2+oscillations in oocytes prior to use andwas injected at a pipette
concentration of 0.01 mg/ml (Nomikos et al., 2013a, b; Nikiforaki et al.,
2014). Control NusA protein was puriﬁed in a similar manner and when
injected separately was used at a pipette concentration of 0.1 mg/ml in
KCl/Hepes buffer.
Statistical analysis
Data on the number of Ca2+ transients and rate of embryo development
from control and experimental groups were analysed using ANOVA or pair-
wise Student’s t-tests. Differences at P, 0.05 were considered signiﬁcant.
Results
Sperm treatment and Ca21 oscillations
after ICSI
To create a clinical scenario mimicking poor fertilization after ICSI, we
exposed mouse sperm to heat treatment since previous studies have
shown that the oocyte activating sperm factor is sensitive to mild heat
treatment (Perry et al., 1999). We incubated mouse sperm at 568C
for time intervals varying from 2.5 to 30 min. Figure 1A–C shows the
recordings of Ca2+ oscillations observed in mouse oocytes after ICSI
with either fresh (control) sperm or with sperm that had been heat
treated for various times such as 20 or 30 min. ICSI using fresh sperm
results in a series of Ca2+ oscillations during the ﬁrst 2 h. In contrast,
any heat treatment of sperm resulted in a signiﬁcantly decreased
number of Ca2+ spikes over the 2 h recording period. ICSI with sperm
that had been heat treated for shorter durations such as 2.5 min pro-
duced some Ca2+ spikes (Fig. 1D), but signiﬁcantly fewer than with
control sperm. ICSI with frozen and thawed sperm caused slightly
fewerCa2+ oscillations in the 2 h recording period than freshly prepared
sperm (Fig. 1D). Figure 1D also shows that the mean number of Ca2+
spikes is progressively reduced as the heat treatment is increased from
2.5 min, with a complete loss of Ca2+ oscillations after ICSI seen with
a 30 min treatment. These data suggest that exposure of sperm at
568C for increasing time periods is associated with a progressive reduc-
tion in the ability of sperm to trigger Ca2+ oscillations.
We further examined the effect of heat-treated ICSI sperm upon the
oocyte activation rate and subsequent development to the blastocyst
stage.We usedMF1 oocytes for this work where control rates of devel-
opment in vitro to the blastocyst stage after fertilization are around 50%
(Ozil and Swann, 1995; Ducibella et al., 2002). Figure 2 and Supplemen-
tary Table S1 show that the rate of oocyte activation, as deﬁned by pro-
nuclear formation, was progressively reduced by heat treating sperm for
2.5–30 min. Similarly, embryonic development to blastocysts was also
reduced in embryos resulting from ICSI with heat-treated sperm.
Figure 2 indicates that an increase in time of sperm exposure to 568C
is consistent with a progressive decrease in the number of ICSI embryos
thatdevelop to the2-cell orblastocyst stage.Thesedata suggest thatmild
heat treatment of mouse sperm leads to loss in the capacity of sperm
to support both Ca2+ oscillations and preimplantation development
after ICSI. The observed thermal impairment of sperm function mimics
a clinical scenario of oocyte activation failure and poor development
after IVF/ICSI.
The most common treatment for failed fertilization after ICSI is to
expose oocytes to Ca2+ ionophores (Nasr-Esfahani et al., 2010).
Figure 3A shows that oocytes injected with sperm heat-treated for
30 min responded with a single large Ca2+ increase after exposure to
ionomycin. For Fig. 3A the ionomycin was washed out after 5 min in
order to mimic the duration of the Ca2+ transient seen in human
oocytes exposed to ionophore (Rinaudo et al., 1997). We then
wanted to compare these stimuli to those that are known to cause
Ca2+ oscillations. First we used Sr2+ media which, as shown in Fig. 3B,
causes a series of Ca2+ oscillations (mean of 7.91 Ca2+ spikes in 2 h,
with a standard deviation of 2.64, n ¼ 15) after ICSI in a manner previ-
ously described (Perry et al., 1999). However, in order to generate the
Ca2+ oscillations in a way that would be effective in human oocytes,
we used recombinant PLCz protein. After ICSI with 30 min heat-treated
sperm, oocyte Ca2+ oscillations could be rescued by microinjection of
recombinant human PLCz (Fig. 3C). The amount of PLCz protein we
used is comparable to that used in previous experiments and was
designed to generate a pattern of Ca2+ oscillations similar to those
seen after ICSI with control sperm. Importantly, we also performed
double injection experiments by injecting PLCz protein into oocytes
that had been through ICSI with control (fresh) sperm (Fig. 4A). For
these double-injected oocytes, there were also Ca2+ oscillations after
PLCz injection, although we cannot distinguish the relative contribution
to these oscillations from the PLCz injection and the injected sperm. It
was, however, notable that the frequency of Ca2+ oscillations in these
experiments was similar to that in control ICSI, or with ICSI using
frozen–thawed sperm (see Fig. 4B).
The above experiments show that Ca2+ signals could be restored by
the use of ionomycin, Sr2+media, or by introducing recombinant PLCz
protein, in oocytes injected with heat-treated sperm. We monitored
oocyte activation and subsequent development in such oocytes.
Figure 5 shows that following ICSI with sperm treated for 30 min and
then incubated with Ca2+ ionophore, oocytes could be activated but
only 13.3% formed blastocysts (see also Supplementary Table S2). In
contrast, whenwe used the same procedure but replaced ionophore ac-
tivation with Sr2+media, or PLCz injection, not only were oocytes acti-
vated but more than 34–36% developed to the blastocysts stage. This is
signiﬁcantlymore thanwith ionophore treatment.We found that the use
of frozen spermwas less effective than fresh sperm in triggering develop-
ment up to the blastocyst stage, but that injection of PLCz could effect-
ively rescue these oocytes and give rise to developmental rates similar to
those of fresh sperm (Supplementary Table S2). These data suggest that
agents that induce Ca2+ oscillations, such as PLCz protein injection,
provide an effective means of rescuing oocyte activation failure or
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poor development after ICSI. We also noted that injecting either PLCz
protein after ICSI using control sperm also led to oocyte activation and
that the rate of 2-cell and blastocyst formation was similar to that seen
with control sperm ICSI alone (Fig. 5 and Supplementary Table S2).
These data show that the injection of PLCz, in addition to a normal
Ca2+ oscillations stimulus from a control sperm, does not appear to
impair preimplantation development to the blastocyst stage.
Discussion
Fertilization failure in an oocyte after ICSI occurs both sporadically in
many treatment cycles and can sometimes occur in all oocytes. Whilst
there may be many reasons for fertilization failure, the most common
cause is failure of oocyte activation (Javed et al., 2010; Nasr-Esfahani
et al., 2010). In this study, we showed that mild heat treatment of
mouse sperm leads to a reduction in its ability to triggerCa2+ oscillations
in mouse oocytes after ICSI. It is known that exposing mouse sperm to
temperaturesof908Cresults inDNAdamage, but that heat treatment
at lower temperatures (568C) does not cause DNA damage nor impair
embryo developmentwhen an independent oocyte activation stimulus is
used (Perry et al., 1999). Our present data conﬁrm that sperm contain a
heat labile factor that triggers Ca2+ oscillations and this sperm-borne
factor is sensitive to relatively mild heat treatment of 568C for 30 min.
This heat treatment is similar to that previously used to inactivate
SOAF (sperm oocyte activating factor) in earlier reports of mouse ICSI
(Perry et al., 1999). Previous ICSI studies also demonstrated that the
SOAF, which is present in the sperm perinuclear theca, is PLCz (Perry
et al., 1999), as identiﬁed by Saunders et al. (2002). PLCz is presently
Figure 1 Intracellular Ca2+measured in mouse oocytes after ICSI. Ca2+ levels are plotted as ﬂuorescence of the Ca2+-sensitive dye, Rhod dextran. In
(A) is shownanexamplewhereanoocytewas injectedwith control fresh sperm (from n ¼ 17 recordings), in (B) anoocytewas injectedwith sperm that has
been heat treated for 20 min (n ¼ 16), in (C) the oocytewas injectedwith spermheat treated for 30 min (n ¼ 13). In (D), themean and standard deviation
of the numberofCa2+ spikes after ICSI is plotted for control spermand for spermexposed todifferent times of heat treatments.One-wayANOVAshows a
signiﬁcant difference between the control sperm and each of the heat-treated sperm samples (P ¼ 0.0092)which is indicated by the * above the bars. Error
bars are SDs.
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the only sperm-speciﬁc protein conﬁrmed to have an intrinsic ability to
cause Ca2+ oscillations in mammalian oocytes by multiple independ-
ent research teams (Saunders et al., 2002; Kurokawa et al., 2004;
Rogers et al., 2004; Miyazaki and Ito, 2006; Nomikos et al., 2014).
Therefore, it is probable that heat treatment leads to sperm PLCz in-
activation in our experiments. Interestingly, freeze thawing of sperm
reduces the activity and distribution of PLCz (Kashir et al., 2011).
This is consistent with our ﬁnding that this step slightly reduces the
number of Ca2+ oscillations after ICSI as well as the percentage of
embryos developing to the blastocyst stage. This could be due to
some PLCz enzyme inactivation due to the freeze thaw cycle, or to
loss of PLCz from the sperm. Nevertheless, in our study, deﬁning
the exact cause of loss of Ca2+ oscillations is not critical since we
have identiﬁed a simple way of mimicking the clinical observation in
humans where sperm from subfertile males shows a reduced ability
to cause Ca2+ oscillations in oocytes after ICSI.
One advantage of using 568C heat treatment to deplete the ability of
spermtoactivateoocytes after ICSI is that it enablesprovisionof different
time points that creates a range of effects. Indeed we found that varying
the duration of sperm heating from 2.5 to 30 min led to progressive loss
of Ca2+ oscillation-inducing activity. Along with the loss of Ca2+ oscilla-
tions, therewas a loss of oocyte activation and embryo development up
to the blastocyst stage. We found that embryo development to the
blastocyst stage fell from 50% down to 0% correlating directly with
the reduced number of Ca2+ spikes caused by increasingly longer heat
treatments. It should be noted that we used mouse oocytes from the
MF1 strain which develop to blastocysts in vitro at a rate of 50%,
which matches clinical scenarios with human embryos. These data sug-
gests that an attenuation of the Ca2+ oscillations following ICSI leads
to decreased rates of oocyte activation and development. This is a
Figure2 The percentage of embryo developmental to the blastocyst
stage after ICSI is compared with that after ICSI using sperm that had
beenheat inactivated for various times.A signiﬁcant difference for devel-
opment to blastocyst was seen from control ICSI for the 10, 20, 30 min
heat treatments (Student’s t-test pairwise between the control and each
heat treatment, P ¼ 0.0038, 0.0023, and 0.000, respectively). Error
bars are SEMs.
Figure3 Intracellular Ca2+measured inmouse oocytes treatedwith
artiﬁcial stimuli after ICSI.Conditions are the sameas in Fig. 1 except that
PE3 was used to record Ca2+ in (B) and (C) where ﬂuorescence is in
arbitrary (ratio) units (a.u.). In (A) is shown an example of oocyte
treated with ionomycin for 5 min (n ¼ 21 recordings) where the bar
indicates the time for which ionomycin was applied. In (B) is an example
of an oocyte injected with heat treatment (30 min) inactivated sperm and
then treated with Sr2+ media (n¼ 12). In (C) is shown an example of an
oocyte injected with heat treatment (30 min) inactivated sperm and then
subsequently injected with puriﬁed recombinant PLCz protein (n¼ 15).
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scenario that appears tooccur in somecasesof subfertility foundbyprac-
titioners of ICSI (Vanden Meerschaut et al., 2013a; Nikiforaki et al.,
2014).
In clinical cases where poor ICSI oocyte activation rates are observed,
the current treatment option is the use of Ca2+ ionophores, which
provide an artiﬁcial stimulus (Neri et al., 2014). It has been used in
many cases of complete activation failure. It can give rise to live births
in treatment cycles that would otherwise fail (Yanagida et al., 2008;
Nasr-Esfahani et al., 2010), but the efﬁciency of this activation protocol
comparedwith a physiological stimulus has not been critically examined.
Ca2+ ionophores can only cause one or, in some protocols, two large
Ca2+ increases, which fails to mimic the multiple Ca2+ oscillations that
occur at fertilization (Vincent et al., 1992; Heytens et al., 2008). In our
study, we tested the ability of ionomycin to overcome failed oocyte ac-
tivation after ICSI with heat-treated sperm and found that it could
restore activation. Ionomycin treatment also lead to development to
the blastocyst stage, but it was less effective than either Sr2+media or re-
combinant PLCz at producing oocyte activations. PLCz recombinant
protein has been previously shown to overcome activation failure after
ICSI in human oocytes (Yoon et al., 2012). This set a precedent for the
use of PLCz as a means of rescuing oocytes from activation failure.
Figure 4 Intracellular Ca2+ measured in oocytes after ICSI. Ca2+
levels are plotted as a ﬂuorescence ratio of the Ca2+ sensitive dye
PE3. In (A) is a representative of oocytes injected with fresh sperm fol-
lowedbyan injectionof hPLCz. (B) Themean frequencyofCa2+oscilla-
tions after injecting hPLCz protein into oocytes that had also been
injected with control fresh or frozen sperm. One-way ANOVA
showed no signiﬁcant difference between the groups (P ¼ 0.169).
Error bars are SDs.
Figure 5 Embryo developmental to blastocyst stage after various ac-
tivation protocols. In (A) embryo developmental rates are shown after
control ICSI, ICSI using heat inactivated sperm (HI) followed by PLCz
injection and ICSI with control sperm followed by PLCz injection.
One-way ANOVA reveals no signiﬁcant difference in development
with a P-value of 0.097. In (B), embryo development is shown after
control ICSI and ICSI using heat inactivated sperm (as in A), and this is
comparedwith ICSI using heat inactivated sperm (HI) followed by treat-
ment with ionomycin or Sr2+ media. The rates of blastocyst develop-
ment after treatment with ionomycin were signiﬁcantly lower when
compared with treatment with hPLCz (t-test pairwise comparisons;
*P ¼ 0.079 for control ICSI versus hPLCz, **P ¼ 0.008 for hPLCz
versus Ionomycin, ***P ¼ 0.093 for hPLCz versus Sr2+). Error bars
are SEMs.
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However, the efﬁciency of activation was not compared with other
protocols. In our current experiments, the higher rates of Sr2+ and
PLCz-mediated oocyte activation versus ionophore-mediated oocyte
activation also lead to better rates of embryo development to the blasto-
cyst. Even though it may not be usable for human oocytes, we used Sr2+
media because it induces Ca2+ oscillations. Consequently our data indi-
cated that it is because PLCz causes Ca2+ oscillations that it is a more
effective stimulus for rescuing oocyte activation after ICSI failure than
Ca2+ ionophores. This is consistentwith previousdata showing thatmul-
tiple Ca2+ transients are the most effective way to activate mouse or
rabbit oocytes (Ducibella et al., 2002, 2006).
In our protocol, we have used a second injection to introduce PLCz
and induced Ca2+ oscillations in the mouse oocyte after ICSI. The use
of a second injection has been used in at least one clinic where Ca2+ is
injected after ICSI, and then ionophores are applied, as part of a protocol
to rescue oocyte from ICSI failure (VandenMeerschaut et al., 2013a, b).
Human oocytes are more robust than mouse oocytes since mouse
oocytes speciﬁcally require piezo devices, or electrical oscillation, for
pipette insertion (Swann, 1990; Yoshida and Perry, 2007). Hence, a
second injection of PLCz protein should be possible in a clinical
setting. We additionally anticipate that introducing PLCz into an oocyte
should be relatively safe for embryos. So far the treatment of oocytes
with Ca2+ ionophores, which produces an unnaturally large rise in
Ca2+, has been shown to have no discernible damaging effect on
embryos or live young (Yanagida, 2004; Vanden Meerschaut et al.,
2013a). PLCz causes Ca2+ oscillations indistinguishable from those
seen at fertilization and so should not lead to any effects upon develop-
ment other than those arising naturally.
Previous studies have suggested that human sperm contain variable
amounts of PLCz and also have a variable ability to cause Ca2+ oscilla-
tions in oocytes (Grasa et al., 2008; Kashir et al., 2013). During ICSI,
an embryologist is unable to assess the ability of a chosen sperm to
causeCa2+oscillations. If PLCz is injected into ICSI oocytes toovercome
cases of suspected activation failure, then it is possible that these oocytes
will receive some endogenous Ca2+ releasing activity from the sperm in
addition to that from the injected PLCz. We tested the developmental
consequence of this by examining the scenario where control sperm
was used for ICSI and then the sameoocyteswere subsequently injected
with the single sperm equivalent dose of PLCz used for rescuing com-
plete activation failure. We also injected PLCz into oocytes that had
ICSIwith frozen–thawed spermand haveonly a slightly reduced number
of Ca2+ oscillations. In both these cases of ICSI + PLCz injection, we
found that after oocyte activation, the development rates to the blasto-
cyst stage were similar to that for control ICSI. This benign effect might
seem surprising since previous studies have shown that PLCz over-
expression can lead to poor development to the blastocyst stage (Yu
et al., 2008). However, the previous deleterious effects on development
required over-expression of about 10-foldmore PLCz than is effective in
causing oocyte activation. In the current study, we estimate that oocytes
should have received little more than double the normal PLCz level in
one sperm. The lack of change in the frequency of Ca2+ oscillations is
consistent with previous studies in mouse oocytes that have found
only a marginal difference in Ca2+ oscillation frequency after fertilization
by two versus one sperm in zona-free oocytes (Faure et al., 1999). These
data suggest thatPLCz canbe injectedat adose to successfully activatean
oocyte that had not been activated by ICSI, and that this will not lead to
detrimental effects on early embryo development.
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